Disclosures: Terrault reports receiving institutional grant support from NIH; institutional grant support for clinical trials from Durect Corp., Eiger Pharmaceuticals, Genentech-Roche, Gilead Sciences, GSK, Helio Health and Madrigal; honoraria for speaking at conferences or other lectures from AASLD, The Asian Pacific Association for the Study of the Liver, Canadian Association for the Study of the Liver (CASL), Duke University, EASL, International Liver Transplantation Society (ILTS), GUILD Conference, Houston Methodist, Iowa University, University of Alabama at Birmingham and University of California; travel accommodations for lectures from AASLD, CASL, EASL, GUILD, ILTS, Iranian Association for the Study of Liver Diseases and Pakistan Society For The Study Of Liver Diseases; serving as president on the governing board of AASLD; serving as a steering committee member for Hepatitis B Foundation and HBV Forum; and being provided with educational materials from Clinical Care Options and Simply Speaking.